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Background
Diabetic retinopathy (DR) is a common complication of diabetes and a leading cause of vision loss in working-aged populations in both advanced and developing countries. [1] Pan-retinal photocoagulation (PRP) is considered the gold standard treatment for severe non-proliferative diabetic retinopathy (NPDR) and proliferative retinopathy (PDR) according to the Early Treatment Diabetic Retinopathy Study (ETDRS). [2] Traditionally, PRP has been performed using various wavelengths, including argon green (514 nm) or diode (810 nm) lasers. However, these lasers have recently been replaced by a pattern scanning laser system that uses a frequency-doubled 532-nm wavelength Nd:YAG laser to avoid patient discomfort and 3 fatigue. Furthermore, the reduced pulse duration required when using the pattern scanning laser may be less painful because of decreased thermal diffusion into the choroid. [3] Several studies have showed that SFChT is affected by treatment, including PRP and intravitreal injections. [4] [5] [6] [7] [8] [9] However, there have been no studies comparing the effect of conventional laser and pattern scanning laser systems on choroidal thickness. It has been reported that PRP performed with the pattern scanning laser is less effective than that performed with a traditional laser for regression of retinal neovascularization in eyes with high-risk PDR. [10] The purpose of this study was to compare the effect of PRP on choroidal thickness using the conventional laser and the pattern scanning laser.
Methods

Subjects
This retrospective interventional comparative study was approved by the institutional review board committee of Chung-Ang University Hospital, Seoul, South Korea, and adhered to the tenets of the Declaration of Helsinki. The medical records of consecutive patients who underwent PRP for severe NPDR or PDR at the Chung-Ang University Hospital between September 1, 2015 and July 31, 2017 and were followed up for at least 12 months were retrospectively reviewed. Signed informed consent was obtained from all patients before each PRP treatment session. The exclusion criteria included prior retinal surgery or photocoagulation, a history of ocular trauma, any history of eye disease, retinal or choroidal disease, refractive error more than ± 3.0 diopters, and systemic disease other than diabetes. Eyes with low-quality OCT images (a low image quality index <60) or media opacities such as 4 vitreous hemorrhage were also excluded.
Study protocol
All patients underwent a comprehensive ophthalmologic evaluation, including measurement of best-corrected visual acuity (BCVA), intraocular pressure, and refractive error, slit-lamp examination, fundus examination, fluorescein angiography, and swept-source OCT. Fluorescein angiography was performed to determine the severity of DR using an ultra-wide-field confocal scanning laser ophthalmoscope (Panoramic 200MA™, Optos PLC, Dunfermline, UK). The severity of DR was graded according to the ETDRS retinopathy severity scale. [2, 11, 12] Sweptsource OCT (DRI Triton OCT, Topcon, Tokyo, Japan) was also performed. This machine uses a wavelength of 1050 nm and a scan speed of 100,000 A-scans per second, and yields an axial resolution of 8 μm and a depth of 2.4 dB/mm. OCT Bscan imaging was performed with a 6 × 6 mm cube scan and a 9 mm five-line crossscan.
The central retinal thickness (CRT) was obtained from an automatic thickness map that was created according to the conventional ETDRS grid in 6 × 6 mm cube scan mode after confirmation of the position of the grid.
SFChT was measured using a built-in caliper tool as the distance between the Bruch membrane and the choroid-sclera interface at the fovea. Retinal thickness was measured automatically. Two independent observers (NP, JTK), who were masked to the clinical data for each patient, measured the choroidal thickness and the averaged values were used for the statistical analysis. 
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Statistical Analysis
The data are presented as the mean ± standard deviation. The CRT, SFChT, reduction in SFChT (ΔSFChT), and rate of reduction in SFChT (%ΔSFChT) were analyzed during follow-up. The statistical analyses were performed using SPSS version 23.0 software (IBM Corp., Armonk, NY, USA) with the independent t-test, paired t-test, and chi-square test as appropriate. A P-value <0.05 was considered statistically significant.
Results
Baseline Characteristics
Sixty-four eyes (38 patients) with severe NPDR (n=27) or PDR (n=37) were included in this study. There were 37 eyes in the conventional laser group and 27 eyes in the pattern laser group. The mean patient age was 55.2 ± 11.7 (range 34-71) years, the mean duration of diabetes was 13.2 ± 5.8 (range 7-22) years, the mean HbA 1c value 6 was 8.0% ± 1.8%, the mean BCVA was 0.24 ± 0.25 logMAR, the mean intraocular pressure was 15.2 ± 3.3 mmHg, and the mean spherical equivalent was -0.73 ± 1.8.
There was no significant difference in age, sex, refractive error, HbA 1c , BCVA, or mean duration of diabetes between the two study groups (Table 1) There was no correlation between the mean baseline SFChT and age (P = 0.138), HbA 1c ( P = 0.237), BCVA (P = 0.747), or spherical equivalent (P = 0.795). The interobserver reproducibility of the SFChT measurement ranged from 0.986 to 0.990. The baseline CRT was similar in both groups and there was no statistically significant difference in the changes in CRT following PRP between the study groups.
Mean subfoveal choroidal thickness in the conventional and pattern laser groups
The mean SFChT in the conventional laser group was 318.4 ± 58.3 μm at baseline and decreased significantly (P < 0.001 vs baseline) at 1, 3, 6 and 12 months, respectively ( Fig 1A, Table 2 ).
The mean SFChT in the pattern laser group was 313.3 ± 91.9 μm at baseline. There were no significant changes in the mean SFChT between baseline and 1 month (309.5 ± 93.4 μm, P = 0.404 vs baseline) after PRP. The mean SFChT were significantly decreased to 309.5 ± 93.4 μm at 3 months (P = 0.404 vs baseline), 301.2 ± 89.6 μm at 6 months (P = 0.004 vs baseline), and 285.1 ± 87.6 μm at 12 months (P < 0.000 vs baseline; Fig 1A, Table 2 ).
ΔSFChT was significantly greater in the conventional laser group than in the pattern laser group at 1 month (14.7 ± 17.3 μm vs 3.8 ± 21.9 μm, P = 0.03), 3 months (20.8 ± 18.6 μm vs 9.4 ± 19.1 μm, P = 0.027), and 6 months (25.3 ± 21.2 μm vs 12.1 ± 18.5 μm, P = 0.018) after PRP. There was no statistically significant difference at 12 months (38.3 ± 19.2 μm vs 28.1 ± 22.8 μm, P = 0.075) after PRP ( Fig 1B, Table 3 ).
The %ΔSFChT was also greater in the conventional laser group than in the pattern laser group at 1 month (4.5% ± 5.1% vs 1.1% ± 7.2%, P = 0.52), 3 months (6.3% ± 5.5% vs 2.7% ± 6.4%, P = 0.03), 6 months (7.8% ± 6.7% vs 3.7% ± 6.4%, P = 0.02), and 12 months (11.9% ± 5.9% vs 8.9% ± 7.2%, P = 0.087; Fig 1C, Table 3 ).
Changes in subfoveal choroidal thickness between the severe NPDR and PDR groups
Thirty-seven of the 64 eyes (38 patients) had PDR and 27 had severe NPDR. The mean SFChT in the PDR group was 319.4 ± 73.5 μm at baseline and decreased significantly through the follow-up period after PRP. The mean SFChT in the severe NPDR group was 309.1 ± 74.3 μm at baseline and also decreased significantly at every time point after PRP ( Fig. 2A , Table 2 ).
The ΔSFChT values in the PDR and severe NPDR groups were 9.9 ± 22.3 μm and 11.7 ± 15.5 μm, respectively, at 1 month, 16.7 ± 20.9 μm and 13.7 ± 16.8 at 3 months, and 24.6 ± 22.5 and 20.9 ± 16.2 at 6 months. There was no statistically significant difference in the amount of reduction in ΔSFChT between the two groups. However, the ΔSFChT was significantly greater in the PDR group than in the severe NPDR group at 12 months after PRP (38.6 ± 22.9 μm vs 24.8 ± 13.7, P = 0.006; Fig.   2B , Table 3 ).
The %ΔSFChT values in the PDR and severe NPDR groups were 2.7% ± 6.9% and 3.6% ± 4.8%, respectively, at 1 month, 4.9% ± 6.5% and 4.4% ± 5.2% at 3 months, and 7.6% ± 7.3% and 7.3% ± 5.6% at 6 months. There was no statistically significant difference in the amount of change in %ΔSFChT between the two groups.
However, the %ΔSFChT was significantly greater in the PDR group than in the severe NPDR group at 12 months after PRP (12.1% ± 7.3% vs 8.1% ± 4.2%, P = 0.01; Fig.   2C , Table 3 ).
Discussion
In this study, we compared the changes in SFChT in eyes with advanced DR after PRP between a conventional laser group and a pattern laser group. There was a significant decrease in SFChT after PRP compared with baseline in both groups of eyes during the follow-up period. The reduction in SFChT was more prominent in the conventional laser group than in the pattern laser group at an early stage following PRP. progressively because of heat diffusion. [13] Therefore, it seems that the difference in the changes in SFChT between the two groups after PRP in this study was related 9 to differences in the expansion of the laser burn scar. Moreover, the laser fluence created by the pattern scanning laser was significantly less than that created by the conventional laser (40.33 J/cm 2 vs 191 J/cm 2 ). [14] Several studies have shown that the SFChT decreases after PRP and that PRPtreated eyes have a smaller SFChT than naïve eyes. [4, 8, 9, [15] [16] [17] Zhang et al. found that the SFChT decreased significantly 3 months after PRP, [8] as did Okamoto et al, [9] while Ohara et al found that SFChT decreased significantly 6 months after PRP [17] and Kang et al reported a significant reduction in the SFChT in the 12 months after PRP. [15] Despite the consistent finding of a decrease in the SFChT during long-term observation, reports on the more short-term studies have been conflicting but suggest a significant increase in SFChT at 1-12 weeks after PRP. [18] [19] [20] It is thought that the inconsistent early changes in SFChT after PRP might be caused by release of inflammatory cytokines in response to laser photocoagulation. Four eyes in our pattern laser group and two eyes in our conventional laser group showed thickening of the SFChT by more than 5%ΔSFChT. It seems that eyes with increased vascular permeability, especially in patients with poor glycemic control, might be more likely to have increased SFChT in the early phase after PRP than eyes in patients with good glycemic control.
We also compared the changes in SFChT after PRP between the PDR and severe NPDR groups. The two groups showed a similar tendency for a decrease in SFChT during the study period. However, the reduction in SFChT was more prominent in the PDR group than in the severe NPDR group at 12 months following PRP. The reduction in SFChT after PRP may be caused by a decrease in the level of vascular endothelial growth factor (VEGF) secreted from the non-perfusion area in response to ablation of an ischemic retina and choriocapillaris. There have been reports of a significant reduction in SFChT in eyes treated with intravitreal injections of anti-VEGF or triamcinolone acetonide as well as PRP. [21] [22] [23] These findings also suggest that the choroid tissue is sensitive to the amount of VEGF or cytokines released from the retinal tissue.
Therefore, we cautiously suggest that an unstable retina with new vessels or diabetic macular edema (DME) would tend to have a thicker SFChT than a stable retina without new vessels or DME. Moreover, we assume that eyes with a more reduced SFChT after conventional PRP would be more stable than eyes with a less decreased SFChT after PRP with pattern laser PRP. We have previously reported choroidal thickening in eyes with advanced DR and choroidal thinning in lasertreated eyes. [4] The findings of the previous studies are consistent in part with the results of the present study and support our theory in terms of the ongoing debate concerning SFChT in eyes with DR or DME. [4] [5] [6] [7] This study has several limitations. First is its small sample size. The second is its retrospective rather than controlled prospective design. Third, recurrence or persistence of new vessels in eyes with PDR after PRP was not considered. Fourth, diurnal variation was not considered. Fifth, the effect of intravitreal anti-VEGF injection was not considered in eyes with DME. However, despite these limitations, this is the first study to compare the effect of pattern scanning laser with that of conventional laser on SFChT after PRP. Further investigations with a prospective design are needed to confirm the findings of the present study.
Conclusions
SFChT is reduced significantly after PRP. However, the effect of conventional laser 11 on the SFChT is greater than that of pattern scanning laser, especially in the early stages after PRP. Table 3 . Comparison of mean subfoveal choroidal thickness between the two study groups during follow-up after panretinal photocoagulation.
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